Microneedle-mediated transdermal delivery of N-acetyl cysteine as a potential antidote for lewisite injury

Lewisite is a chemical warfare agent intended for use in World War and a potential threat to the civilian population due to presence in stockpiles or accidental exposure. Lewisite-mediated skin injury is characterized by acute erythema, pain, and blister formation. N-acetyl cysteine (NAC) is an FDA-approved drug for acetaminophen toxicity, identified as a potential antidote against lewisite. In the present study, we have explored the feasibility of rapid NAC delivery through transdermal route for potentially treating chemical warfare toxicity. NAC is a small, hydrophilic molecule with limited passive delivery through the skin. Using skin microporation with dissolving microneedles significantly enhanced the delivery of NAC into and across dermatomed human skin in our studies. Microporation followed by application of solution (poke-and-solution) resulted in the highest in vitro delivery (509.84 +/- 155.04 mu g/sq & sdot;cm) as compared to poke-and-gel approach (474.91 +/- 70.09 mu g/sq & sdot;cm) and drug-loaded microneedles (226.89 +/- 33.41 mu g/sq & sdot;cm). The lag time for NAC delivery through poke-andsolution approach (0.23 +/- 0.04 h) was close to gel application (0.25 +/- 0.02 h), with the highest for drugloaded microneedles (1.27 +/- 1.16 h). Thus, we successfully demonstrated the feasibility of rapid NAC delivery using various skin microporation approaches for potential treatment against lewisite-mediated skin toxicity.